Stratview Research has published a new report titled “Oncology Drugs Market” which is segmented By Drug Class (Cytotoxic drugs, Targeted drugs, Hormonal drugs, Others), By Therapy (Chemotherapy, Targeted therapy, Immunotherapy), By Indication (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Others) and Region.
As per the study, the Global Oncology Drugs Market is projected to grow from USD 182.56 billion in 2020 to USD 340.27 billion by 2026 at a CAGR of over 10.9% during the forecast period.
Report Highlights
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis -
Based on therapy, the global oncology drugs market has been classified into chemotherapy, targeted therapy, and immunotherapy. Among these, the targeted therapy segment witnessed the highest market share in 2020 and is likely to register a healthy CAGR during the review period. This is mainly ascribed to the identification of molecular targets of cancer cells. Recent developments in cellular technology and gene therapy have further contributed to improving the understanding of tumor cells and their metabolism at the molecular level.
By region, the North America market garnered the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to rising healthcare expenditure, presence of large patient population, early adoption of advance drugs, and increasing senior population, promulgate the product region in the region. Moreover, rise in awareness related to different cancers and a surge in the R&D & innovation activities and further boosts the regional growth.
Who are the Key Players in the Market?
This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Oncology Drugs Market:
· F. Hoffmann-La Roche AG (Switzerland),
· Novartis AG (Switzerland),
· Bristol-Myers Squibb Company (The U.S),
· Merck & Co., Inc. (The U.S),
· Johnson & Johnson (The U.S),
· Pfizer Inc. (The U.S),
· AstraZeneca (UK),
· AbbVie Inc. (The U.S),
· Astellas Pharma Inc. (Japan), and
· CELGENE CORPORATION (The U.S).
Key questions answered by the report
- What is the projected CAGR for revenue from the Oncology Drugs Market during the forecast period?
- What would be the market be valued at by 2026?
- What is a major driving factor for growth of the market?
- Which region accounted for largest revenue share in the Oncology Drugs Market?
- Which are the major market players?
Request a sample- https://www.stratviewresearch.com/Request-Sample/1724/oncology-drugs-market.html#form
Custom Research:
Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.
About Us
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.
Write a comment